A vaccine against elephant endotheliotropic herpesvirus (EEHV), a disease that can kill young elephants within 24 hours of symptoms, is ready for wider use, researchers announced on Friday (October 3).
Breakdown
- A vaccine for the fatal elephant virus EEHV is ready for wider use after successful trials. 6s
- EEHV can cause deadly hemorrhagic disease in young elephants and has been reported in Asia and conservation programs. 18s
- Proof-of-concept trials showed the vaccine is safe and triggers strong immune responses. 40s
- The vaccine was first tested on adult elephants, but the focus is now on protecting calves with weaker immune systems. 1m 20s
- Researchers are working on expanding vaccine delivery and prioritizing at-risk calves. 1m 54s